Published in Biomark Res on September 13, 2013
Smoking as a confounder of the association of suicidality with serum lipid levels. J Psychiatry Neurosci (2016) 0.92
Phenome-Wide Association Study for Alcohol and Nicotine Risk Alleles in 26394 Women. Neuropsychopharmacology (2016) 0.84
Greater decreases in cholesterol levels among individuals with high cardiovascular risk than among the general population: the northern Sweden MONICA study 1994 to 2014. Eur Heart J (2016) 0.77
Cross-sectional study on the relationship between the Mediterranean Diet Score and blood lipids. Nutr J (2014) 0.77
A Role for Behavior in the Relationships Between Depression and Hostility and Cardiovascular Disease Incidence, Mortality, and All-Cause Mortality: the Prime Study. Ann Behav Med (2016) 0.75
Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease. Clin Proteomics (2016) 0.75
Smokers making a quit attempt using e-cigarettes with or without nicotine or prescription nicotine replacement therapy: Impact on cardiovascular function (ISME-NRT) - a study protocol. BMC Public Health (2017) 0.75
A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers. Biomarkers (2015) 0.75
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol (1989) 37.83
Small sample inference for fixed effects from restricted maximum likelihood. Biometrics (1997) 16.06
Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med (1988) 4.98
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry (2009) 4.66
Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA (1982) 4.25
Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med (2010) 4.24
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ (1989) 2.96
Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol (2004) 2.33
Community intervention trials: reflections on the Stanford Five-City Project Experience. Am J Epidemiol (1995) 2.32
Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis (2008) 1.92
Weight gain at the time of menopause. Arch Intern Med (1991) 1.89
Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol (2010) 1.61
A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men. The Israeli CORDIS Study. J Clin Epidemiol (1995) 1.53
Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J (2011) 1.50
Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group. JAMA (1991) 1.37
Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest (1997) 1.27
High-density lipoprotein concentrations increase after stopping smoking. Br Med J (Clin Res Ed) (1982) 1.27
Effects of smoking cessation on weight gain, metabolic rate, caloric consumption, and blood lipids. Am J Clin Nutr (1986) 1.23
The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med (2003) 1.19
Changes in Weight, cardiovascular risk factors and estimated risk of coronary heart disease following smoking cessation in Japanese male workers: HIPOP-OHP study. J Atheroscler Thromb (2010) 1.14
A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. Eur Respir J (1997) 1.11
Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res (2001) 1.10
Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers. Am Heart J (2010) 1.10
Weight gain and adipose tissue metabolism after smoking cessation in women. Int J Obes Relat Metab Disord (2001) 1.04
Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males. Nicotine Tob Res (2003) 0.97
Smoking cessation and change in diastolic blood pressure, body weight, and plasma lipids. MRFIT Research Group. Prev Med (1991) 0.96
Changes in cardiovascular risk profile during the cessation of smoking. Am J Med (1994) 0.92
Endocrine and metabolic effects of smoking cessation. Curr Med Res Opin (2009) 0.91
Variation in serum lipid and lipoprotein levels associated with changes in smoking behaviour in non-obese Caucasian males. Atherosclerosis (1985) 0.90
Effects of smoking cessation on insulin and cardiovascular risk factors--a controlled study of 4 months' duration. J Intern Med (1996) 0.89
The changes of blood glucose control and lipid profiles after short-term smoking cessation in healthy males. Psychiatry Investig (2010) 0.89
Effects of home-based rehabilitation on health-related quality of life and psychological status in Chinese patients recovering from acute myocardial infarction. Heart Lung (2011) 0.87
Acute changes in haematological parameters on cessation of smoking. J R Soc Med (1992) 0.87
Smoking cessation, weight gain, and changes in cardiovascular risk factors during menopause: the Healthy Women Study. Am J Public Health (1998) 0.87
Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). Int J Clin Pharmacol Ther (2004) 0.87
Effects of smoking cessation and weight gain on cardiovascular disease risk factors in Asian male population. Atherosclerosis (2009) 0.85
Raising HDL cholesterol in women. Int J Womens Health (2010) 0.83
Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. J Intern Med (2002) 0.82
Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J R Soc Med (1990) 0.82
Effect of smoking cessation on the number and adhesive properties of early outgrowth endothelial progenitor cells. Int J Cardiol (2010) 0.81
Favorable life-style modification and attenuation of cardiovascular risk factors. Jpn Circ J (1999) 0.81
Smoking cessation and glycaemic control in type 2 diabetic patients. Diabetes Obes Metab (2004) 0.81
Effects of cessation of smoking on serum lipids and high density lipoprotein-cholesterol. Atherosclerosis (1988) 0.81
Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women. J Womens Health (Larchmt) (2011) 0.81
Changes in plasma high density lipoprotein cholesterol after changes in cigarette use. Am J Epidemiol (1986) 0.80
Effects of the transdermal nicotine patch on normalization of HDL-C and its subfractions. Prev Med (2000) 0.79
The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain. Clin Pharmacol Ther (1996) 0.79
Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. J Intern Med (1999) 0.79
Cholesterol changes in smoking cessation using the transdermal nicotine system. Transdermal Nicotine Study Group. Prev Med (1994) 0.79
Smoking and plasma lipoprotein metabolism. Clin Sci (Lond) (1995) 0.78
Longitudinal effect of smoking cessation on physical and laboratory findings. Am J Prev Med (2010) 0.78
Randomized controlled smoking cessation study: transient increase in plasma high density lipoprotein but no change in lipoprotein oxidation resistance. Scand J Clin Lab Invest (1998) 0.78
[Effect of smoking cessation on body mass index, blood pressure and serum lipids in middle-aged male workers]. Nihon Koshu Eisei Zasshi (1998) 0.77
Exercise, smoking cessation, and short-term changes in serum lipids in women: a preliminary investigation. Med Sci Sports Exerc (1998) 0.77
Influence of smoking cessation on carotid artery wall elasticity evaluated by echo-tracking. J Clin Ultrasound (2012) 0.77
Effect of smoking cessation on lipoprotein A-I and lipoprotein A-I:A-II levels. Metabolism (1997) 0.77
Does short-term smoking cessation reduce plasma total homocysteine concentrations? Scand J Clin Lab Invest (2002) 0.77
[Effect of smoking on lipoprotein metabolism]. Med Pregl (2002) 0.77
Lifestyle change and high-density lipoprotein change: the US Department of Veterans Affairs Normative Aging Study. Clin Cardiol (2012) 0.76
Effect of smoking cessation on serum apolipoprotein A-I and A-II concentrations. Pathology (1991) 0.76
High density lipoprotein concentrations after cessation of smoking: the importance of alterations in diet. Atherosclerosis (1989) 0.76
Smoking or its cessation does not alter the susceptibility to in vitro LDL oxidation. Eur J Clin Invest (2000) 0.76
Nicotine gum assisted group therapy in smokers with an increased risk of coronary disease--evaluation in a primary care setting format. Health Educ Res (1992) 0.76
Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis. A control clinical trial. Atherosclerosis (1984) 0.76
Treatment of head louse infestation with 4% dimeticone lotion: randomised controlled equivalence trial. BMJ (2005) 2.41
Randomised, controlled, assessor blind trial comparing 4% dimeticone lotion with 0.5% malathion liquid for head louse infestation. PLoS One (2007) 1.74
Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med (2011) 1.65
Meta-analysis of the relation between European and American smokeless tobacco and oral cancer. BMC Public Health (2007) 1.65
Reassessing the evidence relating smoking bans to heart disease. Regul Toxicol Pharmacol (2011) 1.41
1,2-Octanediol, a novel surfactant, for treating head louse infestation: identification of activity, formulation, and randomised, controlled trials. PLoS One (2012) 1.38
Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer (2012) 1.33
Systematic review of the evidence relating FEV1 decline to giving up smoking. BMC Med (2010) 1.11
Possible effects on smokers of cigarette mentholation: a review of the evidence relating to key research questions. Regul Toxicol Pharmacol (2006) 1.08
How rapidly does the excess risk of lung cancer decline following quitting smoking? A quantitative review using the negative exponential model. Regul Toxicol Pharmacol (2013) 1.06
2-Methoxy antimycin reveals a unique mechanism for Bcl-x(L) inhibition. Mol Cancer Ther (2007) 1.05
Systematic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States. BMC Oral Health (2008) 1.03
Systematic review of the relation between smokeless tobacco and cancer of the pancreas in Europe and North America. BMC Cancer (2008) 0.98
Does use of flue-cured rather than blended cigarettes affect international variation in mortality from lung cancer and COPD? Inhal Toxicol (2009) 0.79
Systematic review with meta-analysis of the epidemiological evidence relating FEV1 decline to lung cancer risk. BMC Cancer (2012) 0.77
Using the negative exponential distribution to quantitatively review the evidence on how rapidly the excess risk of ischaemic heart disease declines following quitting smoking. Regul Toxicol Pharmacol (2012) 0.76
Prevention of head louse infestation: a randomised, double-blind, cross-over study of a novel concept product, 1% 1,2-octanediol spray versus placebo. BMJ Open (2014) 0.75
Further considerations on the evaluation of potential reduced-risk tobacco products. Part II: Re-assessment of a heuristic using the CPS-II database. Regul Toxicol Pharmacol (2009) 0.75
New edition of International Smoking Statistics. Int J Epidemiol (2007) 0.75
Hypotheses and fundamental study design characteristics for evaluating potential reduced-risk tobacco products. Part I: Heuristic. Regul Toxicol Pharmacol (2009) 0.75
The role of ammonia in the transfer of nicotine from tobacco to mainstream smoke. Regul Toxicol Pharmacol (2006) 0.75